 |
FDA Approval Activities for this Drug
Blenoxane (bleomycin sulfate) Injection, USP, Bristol-Myers Squibb Company NDA 50-443/S-035 3/21/03 3/26/03 3/26/03
Bleomycin for Injection USP, 15 units base/vial & 30 units base/vial, Bedford ANDA 65-042 10/17/01 4/10/03
Bleomycin for Injection USP, 15 units base/vial & 30 units base/vial, Gensia Sicor ANDA 65-033 6/27/00 10/30/00
Bleomycin for Injection USP, 15 units base/vial & 30 units base/vial, Faulding Pharmaceutical Co. ANDA 65-031 BLEOMYCIN SULFATE Injection 15 UNITS BASE/VIAL BLEOMYCIN Bedford 065042 BLEOMYCIN SULFATE Injection 30 UNITS BASE/VIAL BLEOMYCIN Bedford 050443 BLEOMYCIN SULFATE Injection 15 UNITS BASE/VIAL BLENOXANE BRISTOL MYERS SQUIBB
050443 BLEOMYCIN SULFATE Injection 30 UNITS BASE/VIAL BLENOXANE BRISTOL MYERS SQUIBB
065031 BLEOMYCIN SULFATE Injection 15 UNITS BASE/VIAL BLEOMYCIN Faulding 065031 BLEOMYCIN SULFATE Injection 30 UNITS BASE/VIAL BLEOMYCIN Faulding 065033 BLEOMYCIN SULFATE Injection 15 UNITS BASE/VIAL BLEOMYCIN Gensia Sicor 064084 BLEOMYCIN SULFATE Injection 15 UNITS BASE/VIAL BLEOMYCIN SULFATE Gensia Sicor 064084 BLEOMYCIN SULFATE Injection 30 UNITS BASE/VIAL BLEOMYCIN SULFATE Gensia Sicor 065033 BLEOMYCIN SULFATE Injection 30 UNITS BASE/VIAL BLEOMYCIN Gensia Sicor Blenoxane (bleomycin sulfate) for injection, Bristol-Myers Squibb, Labeling Revision
For the most up-to-date approval information, please locate this API using the drug index.
|